Antimigraine agents: July 1995 - December 1996

Autor:	Joseph P Yevich
Rok vydání:	1997
Předmět:	Pharmacology Nitric oxide synthetase business.industry Patent literature Antimigraine Agents General Medicine Serotonergic medicine.disease Receptor subtype Migraine Drug Discovery Medicine business Tachykinin receptor Adrenergic Agent
Zdroj:	Expert Opinion on Therapeutic Patents. 7:511-521
ISSN:	1744-7674 1354-3776
DOI:	10.1517/13543776.7.5.511
Popis:	The patent literature pertaining to agents for the treatment of migraine headache and related disorders has been reviewed for the period of July 1, 1995 to December 31, 1996. Included are patents on serotonergic agents, such as 5-hydroxytryptamine 1D (5-HT1D) receptor subtype agonists and 5-HT2 and 5-HT3 antagonists. Also covered are patents describing chemical entities that may be effective in migraine therapy based on their pharmacological actions as adrenergic agents, tachykinin receptor antagonists or inhibitors of nitric oxide synthetase (NOS). Selected references from the recent scientific literature have also been cited.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::4bb9b01a2930dea85fa8d003d8ee0ac8 https://doi.org/10.1517/13543776.7.5.511 Zobrazit plný text záznamu